Li BH - Search Results

1

A Delta-radiomics model for preoperative evaluation of Neoadjuvant chemotherapy response in high-grade osteosarcoma.

Lin P, Yang PF, Chen S, Shao YY, Xu L, Wu Y, Teng W, Zhou XZ, Li BH, Luo C, Xu LM, Huang M, Niu TY, Ye ZM. Lin P, et al. Among authors: li bh. Cancer Imaging. 2020 Jan 14;20(1):7. doi: 10.1186/s40644-019-0283-8. Cancer Imaging. 2020. PMID: 31937372 Free PMC article.

2

Epigenetic alterations in osteosarcoma: promising targets.

Li B, Ye Z. Li B, et al. Mol Biol Rep. 2014 May;41(5):3303-15. doi: 10.1007/s11033-014-3193-7. Epub 2014 Feb 6. Mol Biol Rep. 2014. PMID: 24500341 Review.

3

Analysis of chemotherapy dosage and dosage intensity and survival outcomes of high-grade osteosarcoma patients younger than 40 years.

Sun L, Li Y, Li H, Zhang J, Li B, Ye Z. Sun L, et al. Clin Ther. 2014 Apr 1;36(4):567-78. doi: 10.1016/j.clinthera.2014.02.018. Epub 2014 Mar 14. Clin Ther. 2014. PMID: 24636527 Review.

4

Prognostic value of pathologic fracture in patients with high grade localized osteosarcoma: a systemic review and meta-analysis of cohort studies.

Sun L, Li Y, Zhang J, Li H, Li B, Ye Z. Sun L, et al. J Orthop Res. 2015 Jan;33(1):131-9. doi: 10.1002/jor.22734. Epub 2014 Sep 18. J Orthop Res. 2015. PMID: 25231396 Free article. Review.

5

Induction of a specific CD8+ T-cell response to cancer/testis antigens by demethylating pre-treatment against osteosarcoma.

Li B, Zhu X, Sun L, Yuan L, Zhang J, Li H, Ye Z. Li B, et al. Oncotarget. 2014 Nov 15;5(21):10791-802. doi: 10.18632/oncotarget.2505. Oncotarget. 2014. PMID: 25301731 Free PMC article.

6

Piperine inhibits proliferation of human osteosarcoma cells via G2/M phase arrest and metastasis by suppressing MMP-2/-9 expression.

Zhang J, Zhu X, Li H, Li B, Sun L, Xie T, Zhu T, Zhou H, Ye Z. Zhang J, et al. Int Immunopharmacol. 2015 Jan;24(1):50-8. doi: 10.1016/j.intimp.2014.11.012. Epub 2014 Nov 20. Int Immunopharmacol. 2015. PMID: 25479727

7

Trastuzumab enhanced the cytotoxicity of Vγ9Vδ2 T cells against zoledronate-sensitized osteosarcoma cells.

Liu M, Sun LL, Li YJ, Li HY, Zhang J, Li BH, Ye ZM. Liu M, et al. Among authors: li yj, li hy, li bh. Int Immunopharmacol. 2015 Sep;28(1):160-7. doi: 10.1016/j.intimp.2015.06.002. Epub 2015 Jun 10. Int Immunopharmacol. 2015. PMID: 26071219

8

Prognostic value of IGF-1R expression in bone and soft tissue sarcomas: a meta-analysis.

Liang J, Li B, Yuan L, Ye Z. Liang J, et al. Onco Targets Ther. 2015 Jul 29;8:1949-55. doi: 10.2147/OTT.S88293. eCollection 2015. Onco Targets Ther. 2015. PMID: 26251617 Free PMC article.

9

The role of CTLA-4 and PD-1 in anti-tumor immune response and their potential efficacy against osteosarcoma.

Wang SD, Li HY, Li BH, Xie T, Zhu T, Sun LL, Ren HY, Ye ZM. Wang SD, et al. Among authors: li hy, li bh. Int Immunopharmacol. 2016 Sep;38:81-9. doi: 10.1016/j.intimp.2016.05.016. Epub 2016 May 31. Int Immunopharmacol. 2016. PMID: 27258185 Review.

10

T-Cell-Based Immunotherapy for Osteosarcoma: Challenges and Opportunities.

Wang Z, Li B, Ren Y, Ye Z. Wang Z, et al. Front Immunol. 2016 Sep 14;7:353. doi: 10.3389/fimmu.2016.00353. eCollection 2016. Front Immunol. 2016. PMID: 27683579 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

519 results

Search Page

Filters